Ilex Revitalizes Di-gel And St. Joseph Aspirin Lines Before Relaunching
This article was originally published in The Tan Sheet
Executive Summary
Ilex Consumer Products Group plans to make its mark in the consumer health care products arena by relaunching and “revitalizing iconic American brands,” including the recently acquired di-gel digestive relief brand and St. Joseph Aspirin.
You may also be interested in...
Novartis Opts For OTC Recall, With J&J/McNeil Lessons Still Fresh
After shuttering its Lincoln, Neb., OTC facility, the firm recalls some lots of Bufferin, Excedrin, Gas-X and NoDoz. FDA found a “pattern of problems” when inspecting the plant in 2011, and Novartis’ actions suggest it seeks to avoid the same scrutiny that Johnson & Johnson’s OTC recalls elicited.
FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing
FDA will wield tight oversight of Johnson & Johnson subsidiary McNeil Consumer Healthcare's OTC manufacturing operations under a consent decree filed after the firm's quality-control changes failed to satisfy the agency.
St. Joseph Aspirin Is First J&J/McNeil Divestiture From 2010 OTC Recalls
Johnson & Johnson unloads St. Joseph Aspirin, an OTC brand that suffered a significant dip in sales following a 2010 recall due to contaminated packaging.